Savient Pharmaceuticals Announces Agreement on Use of Cash Collateral

Savient Pharmaceuticals (NASDAQ: SVNT ) announced today that an agreement in principle has been reached by and among Savient, the Official Committee of Unsecured Creditors appointed in Savient's Chapter 11 case (the "UCC") and the Unofficial Committee of Senior Secured Noteholders (the "Unofficial Committee" and, together with Savient and